Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Siemens teams with China's Haifu for HIFU tumour treatment:

This article was originally published in Clinica

Executive Summary

US imaging firm Siemens Medical Solutions and Chinese developer of therapeutic ultrasound systems Chongqing Haifu Technology are to jointly develop a high-intensity focused ultrasound (HIFU) therapy system which uses magnetic resonance imaging (MRI) to guide delivery of treatment. The combination of MRI and HIFU enables improved visualisation of the tumour and allows more precise control of the thermal dose, thereby reducing overall treatment time, said Malvern, Pennsylvania-based Siemens. The main applications of this system will be women's health conditions, including benign uterine fibroids and cancer, and treating tumours of the liver, kidney, pancreas and bone.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel